Results-Based Financing Impact Evaluation 2015
Health Facility Endline Survey
Cameroon, 2015
Get Microdata
Reference ID
CMR_2015_RBFIE-FEL_v01_M
Producer(s)
Damien de Walque
Created on
Jan 30, 2025
Last modified
Jan 30, 2025
Page views
20338
Downloads
14
[14.1631u] Quelle est la présentation de [Oxytocine] ? (f1_14_1631u)
Data file: f1_principal.dta
Overview
Valid:
220
Invalid:
13
Minimum:
2
Maximum:
11
Type:
Discrete
Decimal:
0
Start:
6299
End:
6300
Width:
2
Range:
2 - 11
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | Tube | 0 |
0%
|
| 2 | Comprimé | 3 |
1.4%
|
| 3 | flacon/poche | 2 |
0.9%
|
| 4 | plaquette | 0 |
0%
|
| 5 | sachet | 3 |
1.4%
|
| 6 | kit | 1 |
0.5%
|
| 7 | boîte | 0 |
0%
|
| 8 | ampoule | 86 |
39.1%
|
| 9 | Paquet | 0 |
0%
|
| 10 | unité | 46 |
20.9%
|
| 11 | Injectable | 79 |
35.9%
|
| 12 | sirop | 0 |
0%
|
| 13 | capsule | 0 |
0%
|
| 14 | dose | 0 |
0%
|
| 15 | goutte | 0 |
0%
|
| Sysmiss | 13 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.